5 Key Takeaways

• 1

  The CARDIOCARE study identified gut bacteria linked to heart damage risk during chemotherapy in breast cancer patients.

• 2

  Higher levels of Bacteroidaceae bacteria correlated with increased cardiac biomarkers indicating treatment-induced cardiotoxicity.

• 3

  The study involved 98 women over 60 from three European cancer treatment centers, assessing their gut microbiomes before chemotherapy.

• 4

  Bacteroides was the specific genus found prevalent in patients with elevated cardiotoxicity biomarkers.

• 5

  Future research will expand the study to 600 women to further validate the findings and explore potential probiotic interventions.